News | May 08, 2023
Galmed Pharmaceuticals forms partnership with OnKai
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Subscribe To Our Newsletter & Stay Updated
